YM BioSciences (YMI)
News
| May 29 | $YMI in really good shape and going down... somebody playing with it? Keep going, it will go up withing a week by monteazul |
| May 29 | Good market... bad stocks $YMI $CPST $BPAX by monteazul |
| May 28 | These Biotechs May Break Out While $VVUS And $ARNA Battle It Out. $ASTX $YMI http://stks.co/40Il by abubnic |
| May 28 | These Biotechs May Break Out While Vivus And Arena Battle It Out |
| May 24 | 7 Stocks Under $10 Soaring Higher |
| May 16 | RT @adamfeuerstein RA Capital goes in for 3M shares of $BCRX during Q1. Also 2.3M shares of $YMI and smallish 300K shares of $VVUS. 13F by WolfsBiotechs |
| May 16 | $YMI higher grreat by cjj |
| May 13 | $YMI http://stks.co/3ns1 Bullish breakout from consolidation area. Multiple time frames in alignment. by redline67 |
| May 11 | $YMI over performs the NQ??? by cjj |
| May 11 | YM BioSciences (YMI) Narrows Q1 Loss Street Insider |
| May 11 | YM BioSciences Reports Operational and Financial Results for the Third Quarter of Fis... |
| May 10 | Piper Jaffray Starts YM BioSciences (YMI) at Overweight Street Insider |
Profile
Exchange: AMEX Sector: Healthcare Industry: Biotechnology
1 Year Total Return Performance
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). YM BioSciences is down 43.35% over the last year vs S&P 500 Total Return down 0.60%, Arena Pharmaceuticals up 353.9%, and Incyte Corporation up 21.74%.
- YMI Total Returns
- ^SPXTR Total Returns
- ARNA Total Returns
- INCY Total Returns
Fundamentals
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Cash Flow Statement View Statement
You may also be interested in these YMI related companies
Pro Strategies Featuring YMI
Did YM BioSciences make it into our Pro Portfolio Strategies?
YMI Charts
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Other YMI Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership MSN Money
- SEC Filings SEC
- Technical Charts Chart.ly
- Trading Ideas Benzinga
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| YMI | 1.96 | -0.01 | -0.51% | 297.35M |
| YHOO | 14.92 | -0.32 | -2.10% | 18.11B |
| YGE | 2.68 | +0.08 | +3.08% | 390.18M |
| XRA | 2.04 | +0.22 | +12.09% | 179.23M |
| XPO | 17.10 | -0.76 | -4.26% | 143.13M |
| XPL | 1.07 | +0.07 | +7.00% | 36.63M |
| XPH | 54.39 | -1.22 | -2.19% | |
| XOXO | 8.59 | -0.24 | -2.72% | 231.59M |
| XOP | 45.47 | -2.46 | -5.13% | |
| XOMA | 2.36 | -0.03 | -1.26% | 160.57M |
